Categories: News

TEBillion Welcomes an India-Based System Integrator Company

London, United Kingdom, September 25, 2020 –(PR.com)– TEBillion welcomes an India-based system integrator as part of its user network

The company boasting a diverse clientele and its rich experience in the industry, TEBillion anticipates only a fruitful partnership with the company.

TEBillion has started training 30 sales team over the week and is getting the company ready for the venture.

The partner started as a commercial audio and video solutions provider then grew and expanded into providing more profitable solutions including security surveillance, intelligent lightning, digital surveillance and now, cost-effective business automation solutions aimed for success and growth by TEBillion.

For more information about TEBillion’s Partnership Programs, contact:
Email: pr@tebillion.email
Website: www.tebillion.com

About TEBillion: TEBillion is a business automation software solutions company headquartered in the UK. Born in 2018, TEBillion aims to make high growth businesses successful with over a hundred handpicked partners serving customers, worldwide

Let’s block ads! (Why?)

Miscw.com

Recent Posts

Graphisoft Takes Center Stage as Title Sponsor at Singapore Archifest 2024, Showcasing Innovation and Leadership in Architecture

Singapore and regional Industry professionals can anticipate Graphisoft’s latest BIM product innovations, including BIMx on…

5 mins ago

Discovery Taiwan And MediaTek Collaborate On New Short Documen-tary, CHASING BREAKTHROUGH

SINGAPORE - Media OutReach Newswire - 16 May 2024 - Discovery Taiwan and MediaTek have…

19 mins ago

Leading Hong Kong Law Firm Oldham, Li & Nie Pioneers Elder Law Practice to Serve the Community

HONG KONG SAR - Media OutReach Newswire - 16 May 2024 - Oldham, Li &…

19 mins ago

Cyber Attack-Data Breach is Top Business Risk Facing Financial Institutions, Aon Survey

HONG KONG SAR - Media OutReach Newswire - 16 May 2024 - Aon plc (NYSE:…

20 mins ago

InnoCare Announces the Completion of Patient Enrollment in the Phase II Clinical Trial of ICP-488 for the Treatment of Psoriasis

BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment…

2 hours ago

Oasis Calls for Improved Shareholder Return & Votes Against Chairman, Two Directors at Kumagai Gumi

(Stock Code: 1861 JT) *Oasis proposes a dividend of JPY160 per share *Oasis recommends shareholders…

3 hours ago